Guangzhou Baiyunshan Pharmaceutical Group Company Limited, China Resources Sanjiu, Pharmaceutical Company Limited, China National Traditional Chinese Medicine Holding Company Limited, Shandong Buchang Pharmaceutical Company Limited, Tiantuili Pharmaceutical Group Company Limited, Beijing Tongrentang Company Limited, Jichuan Pharmaceutical Group Company Limited, Zhangzhou Katazai pain Pharmaceutical Company Limited, Jilin Aodong Ltd., Tianjin Zhongxin Pharmaceutical Group Co., Ltd., Kun Pharmaceutical Group Co., Ltd., Shijiazhuang Ealing Pharmaceutical Co. Ltd. Tianjin Hongri Pharmaceutical Co.
Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. is an enterprise with the wholesale of western pharmaceuticals, the wholesale of medical diagnostic, monitoring and therapeutic equipment, and the wholesale of chemical products as its main business.
On July 20, 2021, the 2021 Fortune China 500 list was released, and Guangzhou Baiyunshan Pharmaceutical Group Co. was ranked 184th.
Chinese Resources Sanjiu Medicine Co., Ltd, referred to as China Resources Sanjiu, is a large state-controlled pharmaceutical listed companies, is a subsidiary of China Resources Pharmaceuticals under the China Resources Group, the predecessor of the "Shenzhen Nanfang Pharmaceutical Factory" established by Zhao Xinxian in 1985, which was put into production in 1987. On March 9, 2000, the company was listed on the Shenzhen Stock Exchange, and formally entered the China Resources Group at the end of November 2007, and in February 2010, the company's name was formally changed from "Sanjiu Pharmaceutical Company Limited" to "China Resources Sanjiu Pharmaceutical Company Limited". The company's main business is non-prescription drugs and prescription Chinese medicines, and its main products are Sanjiu Gastrotherapy, 999 Cold and Flu, 999 Piyanping, 999 Pediatric Aminophenol, 999 Zhengtian Pill, 999 Strong Pei Pa Koa, Gas Stagnation Gastroparesis Pellet, 999 Ginseng and Forsythia Injections, and 999 Ginseng and Mai Injections etc. The company is also a member of the China Resources Group, which is the largest pharmaceutical company in the world.
China National Traditional Chinese Medicine Holdings Limited ("CNMH") is the core platform of Sinopharm's traditional Chinese medicine industry. The company is listed on the Main Board of the Stock Exchange of Hong Kong and its head office is located in Foshan, Guangdong Province. The company employs about 15,000 people and has 83 subsidiaries.